Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 10271-10280 of 11953

Edit search filters
  1. Financial Toxicity Among Patients In Phase I Clinical Trials

    Rochester, MN

  2. A Study To Identify Risk Factors From Any Reason For Hospital Readmission, Death, Or Declining Health In Older Persons Who Were Hospitalized With A Heart Attack

    Rochester, MN

  3. Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

    Rochester, MN

  4. A Study To Evaluate The Efficacy Of A Hybrid Imaging And Measurement Tool For Breast Cancer Detection And Monitoring

    Rochester, MN

  5. A Study To Develop A Hypertrophic Cardiomyopathy Registry

    Rochester, MN

  6. VEXAS Biobank

    Rochester, MN

  7. Practice and Education Gaps in Cosmetic Dermatology

    Rochester, MN

  8. Mediators of insulin resistance in women with a history of gestational diabetes mellitus

    Rochester, MN

  9. A Study to Optimize Patient Selection and Outcomes in Laryngeal Vascular Composite Allograft Transplantation

    Scottsdale/Phoenix, AZ

  10. Biobank Protocol, Rare Diseases Clinical Research Network

    Rochester, MN

.

Mayo Clinic Footer